Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trialJordi Bruix, Josep M. Llovet, Jean‐Luc Raoul et al.|Journal of Hepatology|2012Cited by 821
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Lorenza Rimassa et al.|The Lancet Oncology|2012Cited by 550
Prokinetics in Patients with Gastroparesis: A Systematic AnalysisAndreas Sturm, Guido Gerken, Gerald Holtmann et al.|Digestion|1999Cited by 214
Small Bowel Homing T Cells Are Associated With Symptoms and Delayed Gastric Emptying in Functional DyspepsiaTobias Liebregts, Gerald Holtmann, Nicholas J. Talley et al.|The American Journal of Gastroenterology|2011Cited by 192
LB01 SIX WEEKS OF SOFOSBUVIR/LEDIPASVIR TREATMENT OF ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: FINAL RESULTS OF THE THE GERMAN HEPNET ACUTE HCV IV STUDYKatja Deterding, Maurizio Degiuli, Christoph D. Spinner et al.|United European Gastroenterology Journal|2016Cited by 5